XML 20 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Jul. 31, 2014
Jul. 31, 2013
Cash flows from operating activities:    
Net earnings $ 1,260 $ 1,617
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:    
Depreciation 628 631
Bad debt provision 26 29
Stock based compensation expense 58 59
Provision for deferred income tax expense (15) (35)
Change in assets and liabilities:    
(Increase) decrease in receivables (2,262) 1,103
(Increase) decrease in inventories (275) 869
Increase (decrease) in accounts payable and other accrued expenses 877 (2,105)
Increase in deferred revenue 146 160
Other, net (638) (523)
Net cash (used in) provided by operating activities (195) 1,805
Cash flows from investing activities:    
Capital expenditures (541) (528)
(Increase) decrease in restricted cash (1,968) 72
Net cash used in investing activities (2,509) (456)
Cash flows from financing activities:    
Dividends paid (288) (260)
Increase (decrease) in short-term borrowings and interest rate swap 2,064 (1,896)
Proceeds from long-term debt   5,000
Payments on long-term debt (105) (3,504)
Payment toward purchase of noncontrolling interest in subsidiary (888) (1,780)
Net proceeds from exercise of stock options (including tax benefit)   57
Net cash provided by (used) in financing activities 783 (2,383)
Effect of exchange rate changes on cash 41 (369)
Decrease in cash and cash equivalents (1,880) (1,403)
Cash and cash equivalents, beginning of period 6,248 5,811
Cash and cash equivalents, end of period 4,368 4,408
Supplemental Disclosure of Cash Flow Information    
Purchase of noncontrolling interest in subsidiary - other accrued expenses and other non-current liabilities   $ 1,775